Copyright © 2008 The American Society of Human Genetics. All rights reserved.
The American Journal of Human Genetics, Volume 82, Issue 4, 1003-1010, 13 March 2008
doi:10.1016/j.ajhg.2008.01.013
Report
Gregor D. Gilfillan1, 2, 15, Kaja K. Selmer1, 2, 15, Ingrid Roxrud3, Raffaella Smith4, Mårten Kyllerman5, Kristin Eiklid1, Mette Kroken1, Morten Mattingsdal1, Thore Egeland1, Harald Stenmark3, Hans Sjøholm6, Andres Server7, Lena Samuelsson8, Arnold Christianson9, Patrick Tarpey4, Annabel Whibley10, Michael R. Stratton4, P. Andrew Futreal4, Jon Teague4, Sarah Edkins4, Jozef Gecz11, Gillian Turner12, F. Lucy Raymond10, Charles Schwartz13, Roger E. Stevenson13, Dag E. Undlien1, 2 and Petter Strømme2, 14,
, 
1 Department of Medical Genetics, Ullevål University Hospital, NO-0407 Oslo, Norway
2 Faculty Division, Ullevål University Hospital, Faculty of Medicine, University of Oslo, NO-0316 Oslo, Norway
3 Department of Biochemistry, Institute for Cancer Research, Rikshospitalet-Radiumhospitalet Medical Center, NO-0310 Oslo, Norway
4 Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK
5 The Queen Silvia Children's Hospital, Gothenburg University, S-416 85 Gothenburg, Sweden
6 Section for Neurophysiology, Department of Neurology, Ullevål University Hospital, NO-0407 Oslo, Norway
7 Department of Neuroradiology, Ullevål University Hospital, NO-0407 Oslo, Norway
8 Department of Clinical Genetics, Sahlgrenska University Hospital, Gothenburg University, S-416 85 Gothenburg, Sweden
9 Division of Human Genetics, National Health Laboratory Service and University of Witwatersrand, Johannesburg 2000, South Africa
10 Cambridge Institute of Medical Research, Cambridge, CB2 0XY, UK
11 Neurogenetics Laboratory, Department of Genetic Medicine, Women's and Children's Hospital, North Adelaide, SA 5006, Australia
12 Hunter Genetics and University of Newcastle, Newcastle, NSW 2300, Australia
13 Greenwood Genetic Center, JC Self Research Institute of Human Genetics, Greenwood, SC 29646, USA
14 Department of Pediatrics, Ullevål University Hospital, NO-0407 Oslo, Norway
Corresponding authorAbstract
Linkage analysis and DNA sequencing in a family exhibiting an X-linked mental retardation (XLMR) syndrome, characterized by microcephaly, epilepsy, ataxia, and absent speech and resembling Angelman syndrome, identified a deletion in the SLC9A6 gene encoding the Na+/H+ exchanger NHE6. Subsequently, other mutations were found in a male with mental retardation (MR) who had been investigated for Angelman syndrome and in two XLMR families with epilepsy and ataxia, including the family designated as having Christianson syndrome. Therefore, mutations in SLC9A6 cause X-linked mental retardation. Additionally, males with findings suggestive of unexplained Angelman syndrome should be considered as potential candidates for SLC9A6 mutations.
| Is the Transportation Highway the Right Road for Hereditary Spastic Paraplegia? The American Journal of Human Genetics, Volume 71, Issue 5, 1 November 2002, Pages 1009-1016 Andrew H. Crosby and Christos Proukakis Abstract The term “hereditary spastic paraplegia” (HSP) refers to a genetically and clinically diverse group of disorders whose primary feature is progressive spasticity of the lower extremities. The condition arises because of degeneration of the longest motor and sensory axons on the spinal cord, which appear to be most sensitive to the underlying mutations. The marked genetic heterogeneity in HSP, with 20 loci chromosomally mapped and eight genes now identified, suggests that a number of defective cellular processes may be shown to result in the disease. Although previous studies have suggested a mitochondrial basis for at least one form of the disease, a mechanism common to a number of the other genes mutated in HSP has remained elusive until now. The identification of the most recent genes for the condition suggests that aberrant cellular-trafficking dynamics may be a common process responsible for the specific pattern of neurodegeneration seen in HSP. Abstract | | |
| ZFYVE27 (SPG33), a Novel Spastin-Binding Protein, Is Mutated in Hereditary Spastic Paraplegia The American Journal of Human Genetics, Volume 79, Issue 2, 1 August 2006, Pages 351-357 Ashraf U. Mannan, Philip Krawen, Simone M. Sauter, Johann Boehm, Agnieszka Chronowska, Walter Paulus, Juergen Neesen and Wolfgang Engel Abstract Spastin, the most commonly mutated protein in the autosomal dominant form of hereditary spastic paraplegia (AD-HSP) has been suggested to be involved in vesicular cargo trafficking; however, a comprehensive function of spastin has not yet been elucidated. To characterize the molecular function of spastin, we used the yeast two-hybrid approach to identify new interacting partners of spastin. Here, we report ZFYVE27, a novel member of the FYVE-finger family of proteins, as a specific spastin-binding protein, and we validate the interaction by both in vivo coimmunoprecipitation and colocalization experiments in mammalian cells. More importantly, we report a German family with AD-HSP in which ZFYVE27 (SPG33) is mutated; furthermore, we demonstrate that the mutated ZFYVE27 protein shows an aberrant intracellular pattern in its tubular structure and that its interaction with spastin is severely affected. We postulate that this specific mutation in ZFYVE27 affects neuronal intracellular trafficking in the corticospinal tract, which is consistent with the pathology of HSP. Abstract | | |
| Cold-Induced Sweating Syndrome Is Caused by Mutations in the CRLF1 Gene The American Journal of Human Genetics, Volume 72, Issue 2, 1 February 2003, Pages 375-383 Per M. Knappskog, Jacek Majewski, Avi Livneh, Per Torgeir E. Nilsen, Jorunn S. Bringsli, Jürg Ott and Helge Boman Abstract In 1978, Sohar et al. described a strikingly peculiar syndrome in two Israeli sisters. These young women responded to environmental temperatures of 18°C–7°C with profuse sweating on large segments on their back and chest. Both had additional abnormalities, including a high-arched palate, nasal voice, depressed nasal bridge, inability to fully extend their elbows, and kyphoscoliosis. We have observed this disorder in two Norwegian brothers. Genomewide screening in the two families, followed by saturation marker studies and linkage analysis, identified a 1.4-Mb homozygous candidate region on chromosome 19p12. The maximum multipoint LOD score was 4.22. In both families, DNA sequencing of 25 genes within the candidate region identified potentially deleterious CRLF1 sequence variants that were not found in unaffected control individuals. Our findings confirm that the cold-induced sweating syndrome is an autosomal recessive disorder that is probably caused by impaired function of the CRLF1 gene, and they suggest important developmental functions for human CRLF1. Abstract | | |